10.4 Adult Urinary Tract Infection and Dysuria

Key Takeaways

  • Use symptoms and examination to localise urinary infection. Fever, flank pain, retention and systemic illness change the pathway.

  • Use the HSE community regimen for the appropriate patient group and confirm the formulation, renal function and relevant product information.

  • Treat symptomatic infection. Use the pregnancy and procedure-specific pathways for the main exceptions involving asymptomatic bacteriuria.

Last updated: November 2026

Localise the symptoms before choosing a test

Ask what changed and when. New dysuria, urgency and frequency, with or without suprapubic discomfort, support lower UTI. Flank pain, rigors, nausea or vomiting and costovertebral tenderness raise concern for upper infection. Assess vital signs, hydration and ability to take oral treatment. Ask about pregnancy, catheter use, stones, renal function, recent antibiotics and prior cultures. If discharge or sexual exposure suggests urethritis, take a sexual history and use the appropriate STI tests. Persistent frequency or dysuria can also arise from genitourinary syndrome of menopause, vulvovaginal irritation, bladder dysfunction or outlet obstruction.

PresentationDecision that changes management
Non-pregnant woman younger than 65 with symptoms of uncomplicated cystitisDecide from the history and examination. Dipstick can assist when uncertain. Nitrite, or leucocytes together with blood, increases the likelihood. Routine culture is usually unnecessary in a first straightforward episode. Send a midstream urine sample if there has been recent antibiotic exposure or symptoms fail to improve after 48 hours of first-line treatment.
Man with new lower urinary symptomsSend midstream urine for culture before treatment. Perineal pain, fever, malaise or retention raise concern for acute bacterial prostatitis. Use the prostatitis pathway and a drug that reaches prostatic tissue. Nitrofurantoin has poor prostatic penetration.
Adult aged 65 or over or anyone with an indwelling catheterAssess symptoms and signs rather than using dipstick to assess for UTI. Cloudy or malodorous urine alone is insufficient. New delirium warrants assessment for several causes. If fever, localising signs or systemic illness coexist, assess promptly for infection and other illness.
Fever and flank pain, or systemic illness with suspected urinary obstructionConsider pyelonephritis. Obtain culture before antibiotics when this can be done promptly. If sepsis or infected obstruction is suspected, arrange emergency hospital care. An infected obstructed kidney needs antibiotics and urgent urological drainage.

In a catheterised patient with clinical suspicion of infection, collect the specimen aseptically from the designated sampling port, using the local method. The drainage bag is unsuitable for culture. Review whether the catheter is still needed. The HSE community decision aid advises replacing one that is still needed and has been in place for more than two weeks while the patient is on antibiotics for catheter-associated UTI. A positive culture alone can indicate colonisation. The usual exceptions to withholding treatment for asymptomatic bacteriuria are pregnancy and planned urological procedures that breach the mucosa.

HSE dipstick position statements · HSE older adult and catheter decision aid · HSE catheter-associated UTI · HSE acute prostatitis · Cavan General Hospital laboratory manual.

Choose the Irish community regimen for the clinical setting

For an otherwise suitable adult with uncomplicated lower UTI, HSE AMRIC lists nitrofurantoin immediate release 50 mg orally every six hours or prolonged release 100 mg orally every 12 hours. Use the formulation-specific schedule. The usual HSE course for a non-pregnant woman younger than 65 is three days. The guideline allows consideration of five days for a history of recurrence or inadequate response. For a man with uncomplicated lower UTI and no suspicion of prostatitis, the HSE course is seven days after collecting the pretreatment urine. Check renal function, allergies, other contraindications and recent cultures. Consider a back-up prescription for selected women with mild symptoms and low risk of complications, with clear instructions about worsening or no improvement by 48 hours.

The HSE prescribing course and the HPRA product label are separate references. The September 2026 MacroBid prolonged-release SmPC lists seven days for uncomplicated lower UTI and contraindicates use below eGFR 45. The HSE short-course community guidance describes a lower limit and selected resistant-pathogen circumstances. When renal function is reduced, check the exact product and seek prescriber or antimicrobial advice before any departure from the label. The worked example has satisfactory renal function.

Nitrofurantoin has inadequate tissue concentrations for pyelonephritis. For adults suitable for oral community treatment of pyelonephritis, the HSE first-choice example is cefalexin 500 mg every eight hours for seven to ten days when suitable, avoiding cephalosporins in severe penicillin allergy under that guideline. Review the culture and clinical progress. Consider hospital referral if there is no response in 24 hours. Significant dehydration, inability to take oral treatment, severe systemic illness, pregnancy or a higher risk of complications prompt assessment for hospital treatment from the outset.

HSE uncomplicated UTI in non-pregnant women · HSE uncomplicated UTI in men · HSE acute pyelonephritis · HPRA MacroBid product information.

Test Your Knowledge

A 31-year-old non-pregnant woman has new dysuria and frequency without fever, flank pain, vaginal symptoms or a catheter. Her eGFR is 87 mL/min/1.73 m². She has no relevant allergies or contraindications, recent antibiotic exposure or history of recurrence. You and the patient decide to start an antibiotic now. Which regimen is first choice under HSE AMRIC community guidance for this presentation?

A

Nitrofurantoin prolonged release 100 mg orally every 12 hours for three days

B

Nitrofurantoin immediate release 50 mg orally every 12 hours for three days

C

Cefalexin 500 mg orally every eight hours for ten days as for upper UTI

D

Ciprofloxacin 500 mg orally every 12 hours for seven days

Confirm recurrence before committing to prevention

In the HSE guidance, at least two episodes in six months or at least three in 12 months meets the frequency criterion for recurrent UTI. Establish that episodes were symptomatic and supported by culture. Repeated symptoms with negative cultures prompt review of the diagnosis. Use prior susceptibility results, distinguish recurrence after apparent recovery from persistent symptoms on treatment, and consider specialist review for men, pregnancy, recurrent upper-tract infection or suspected structural or functional problems.

For a non-pregnant woman with confirmed uncomplicated recurrence, discuss practical non-antibiotic measures first. Consider vaginal oestrogen after menopause where appropriate. If prevention is still needed, agree the risks and benefits of prophylaxis and select an antibiotic with confirmed susceptibility. A clear trigger can support a single-dose regimen linked to that trigger. Review antimicrobial prophylaxis after three to six months. Seek earlier reassessment for fever, flank pain, vomiting or clinical deterioration.

HSE recurrent UTI guidance.

Test Your Knowledge

An 81-year-old residential-care patient with a long-term urinary catheter has cloudy urine and a culture sent before review that grew bacteria. On assessment the patient is well, afebrile and at cognitive baseline, with no flank or suprapubic pain or other new signs. No mucosa-breaching urological procedure is planned. What is the most appropriate response?

A

Give nitrofurantoin for three days because growth confirms symptomatic cystitis

B

Use dipstick to determine whether the culture represents infection

C

Start antibiotic prophylaxis and repeat the culture weekly

D

Review catheter need and avoid antibiotics for the current culture finding

Sections you finish are checked off in the contents.